# US 2025/0027060 A1 · Crystal Structures of ALK and LTK Receptor Tyrosine Kinases and Their Ligands

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2025/0027060 A1
- Document ID: US20250027060A1
- Status: Published application
- Kind: A1
- Application number: 18/577,139
- Filed: 2022-07-04
- Published: 2025-01-23
- Earliest claimed: 2021-07-07
- Assignees: Vib Vzw; Universiteit Gent
- Applicants: Vib Vzw; Universiteit Gent
- Inventors: Savvas Savvides; Steven De Munck
- Web page: https://patentgrep.com/patent/US20250027060A1

## CPC

- C12N 9/12: transferring phosphorus containing groups, e.g. kinases (2.7)
- C07K 14/52: Cytokines; Lymphokines; Interferons
- C07K 14/715: for cytokines; for lymphokines; for interferons
- C12Y 207/10001: Receptor protein-tyrosine kinase (2.7.10.1)
- G16B 15/30: Drug targeting using structural data; Docking or binding prediction
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)
- C07K: PEPTIDES (peptides in foodstuffs A23; obtaining protein compositions for foodstuffs, working-up proteins for foodstuffs A23J; preparations for medicinal purposes A61K; peptides containing beta-lactam rings C07D; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, C07D; ergot alkaloids of the cyclic peptide type C07D519/02; macromolecular compounds having statistically distributed amino acid units in their molecules, i.e. when the preparation does not provide for a specific; but for a random sequence of the amino acid units, homopolyamides and block copolyamides derived from amino acids C08G69/00; macromolecular products derived from proteins C08H1/00; preparation of glue or gelatine C09H; single cell proteins, enzymes C12N; genetic engineering processes for obtaining peptides C12N15/00; compositions for measuring or testing processes involving enzymes C12Q; investigation or analysis of biological material G01N33/00)
- C12Y: ENZYMES
- G16B: BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY

## Abstract

The present invention provides co-crystals of the anaplastic lymphoma kinase (ALK) and its ligand ALKAL2 and the related leukocyte tyrosine kinase (LTK) and its ligand ALKAL1. The invention also provides computer-assisted and other methods for selecting molecules able to modulate the interaction between ALK, LTK and their respective ligands.

## Claims

### Claim 1

A composition comprising a crystalline form selected from i) ALKTG (SEQ ID NO: 1) interacting with ALKAL2 (SEQ ID NO: 2) and ii) LTKTG (SEQ ID NO: 3) interacting with ALKAL1 (SEQ ID NO: 4) and Nb3.16 (SEQ ID NO: 5), characterized in that the crystals are:
i) a crystal between ALKTG (SEQ ID NO: 1) interacting with ALKAL2 (SEQ ID NO: 2) in the space group P43212, with the following crystal lattice constants: a=97.57 Å±5%, b=97.57 Å±5%, c=355.35 Å±5%, α=β=γ=90°, and
ii) a crystal between LTKTG (SEQ ID NO: 3) interacting with ALKAL1 (SEQ ID NO: 4) and Nb3.16 (SEQ ID NO: 5) in the space group P61, with the following crystal lattice constants: a=129.11 Å±5%, b=129.11 Å±5%, c=109.75 Å±5%, α=90°, β=90°, γ=120°.

### Claim 2 (depends on 1)

The composition of claim 1, wherein the crystalline form has a three-dimensional structure comprising i) an atomic structure characterized by the coordinates depicted in the entry ID 7NWZ present in the on line RCSB protein database on Mar. 17, 2021 and/or ii) an atomic structure characterized by the coordinates depicted in the entry ID 7NX0 present in the on line RCSB protein database on Mar. 17, 2021.

### Claim 3

(canceled)

### Claim 4 (depends on 1)

A method for identifying a compound that binds to the complex i) ALKTG-ALKAL2 or to the complex ii) LTKTG-ALKAL1-Nb3.16 of claim 1, the method comprising:
dipping candidate small molecule compounds with the complex ALKTG-ALKAL2 or the complex LTKTG-ALKAL1-Nb3.16L,
allowing co-crystallization, and screening candidate agonists or antagonists by using a method for measuring intermolecular interaction and
comparing, designing, and docking an
a candidate ligand, and
i) an atomic structure characterized by the coordinates depicted in the entry ID 7NWZ present in the on line RCSB protein database on Mar. 17, 2021 and/or ii) an atomic structure characterized by the coordinates depicted in the entry ID 7NX0 present in the on line RCSB protein database on Mar. 17, 2021, by computer modeling.

### Claim 5

A method of identifying, designing or screening for a compound that can interact with the complex i) ALKTG-ALKAL2 or to the complex ii) LTKTG-ALKAL1-Nb3.16, the method comprising:
performing structure-based identification, design, or screening of a test compound based on the test compound's interactions with the complex i) ALKTG-ALKAL2 or to the complex ii) LTKTG-ALKAL1-Nb3.16.

### Claim 6

A method for identifying an agonist or antagonist compound for the interaction between the members of the complex i) ALKTG-ALKAL2 or the complex ii) LTKTG-ALKAL1-Nb3.16L, the compound comprising an entity selected from the group consisting of an antibody, a peptide, a non-peptide molecule and a chemical compound, wherein the compound enhances or disrupts the interaction of the members of the complex i) ALKTG-ALKAL2 or the complex ii) LTKTG-ALKAL1-Nb3.16, the method comprising:
i) introducing into suitable computer program parameters defining an interacting surface based on the conformation of the complex i) ALKTG-ALKAL2 or the complex ii) LTKTG-ALKAL1-Nb3.16 corresponding to the atomic coordinates 7NWZ or 7NX0 present in the on line RCSB protein database on Mar. 17, 2021, wherein said program displays a three-dimensional model of the interacting surface,
ii) creating a three-dimensional structure of a test compound in the computer program; and
displaying a superimposing model of the test compound on the three-dimensional model of the interacting surface.
